Medicine and Dentistry
Chimeric Antigen Receptor
73%
Antineoplastic Activity
58%
T Cell
57%
Co-Stimulation
44%
T-Cell Signaling
33%
Glucose Transporter 5
33%
Cell Therapy
33%
Chimeric Antigen Receptor T-Cell
20%
Solid Malignant Neoplasm
20%
Receptor
18%
Tumor Cell
13%
Neoplasm
12%
CD3 Antigen
12%
Target Cell
6%
Xenograft
6%
Single Chain Fragment Variable Antibody
6%
Alanine
6%
Combination Therapy
6%
Fructose
6%
T Lymphocyte Receptor
6%
Interleukin 2
6%
Tumor Microenvironment
6%
Vascularity
6%
Mutagenesis
6%
In Vitro
6%
Metabolite
6%
Clinical Trial
6%
Medical Decision Making
6%
Cancer
6%
Cancer Immunotherapy
6%
Immunotherapy
6%
Artificial Receptor
5%
Hematologic Malignancy
5%
Cytokine Release
5%
Cytokine Signaling
5%
Immune Response
5%
T Cell Exhaustion
5%
Immunology and Microbiology
Chimeric Antigen Receptor
73%
CD28
66%
Antineoplastic Activity
55%
T Cell
55%
Co-Stimulation
44%
T-Cell Signaling
33%
CD19
33%
Chimeric Antigen Receptor T-Cell
16%
Tumor Cell
12%
CD3 Antigen
11%
T Cell Receptor
6%
Renewable Energy
6%
Metabolite
6%
Medical Decision Making
6%
Vascularization
6%
Cancer Immunotherapy
6%
Target Cell
5%
Single-Chain Variable Fragment
5%
Cytokine Release
5%
Xenograft
5%
Alanine
5%
Immunotherapy
5%
Immune Response
5%
Mutagenesis
5%
Cytokine Signaling
5%
Interleukin 2
5%
T Cell Exhaustion
5%
Biochemistry, Genetics and Molecular Biology
Chimeric Antigen Receptor
100%
T Cell
70%
CD28
66%
Avidity
33%
Signal Transduction
33%
CD19
33%
Antineoplastic Activity
18%
ErbB
11%
Cell Membrane
11%
Tissue Culture
11%
Cytokine
5%
Cytokine Release
5%
Immune Response
5%
